AAAAAA
Results:
1-16
|
Results: 16
Authors:
Chew, DP
Bhatt, DL
Lincoff, AM
Moliterno, DJ
Brener, SJ
Wolski, KE
Topol, EJ
Citation: Dp. Chew et al., Defining the optimal activated clotting times during percutaneous coronaryintervention: Aggregate results from 6 randomized, controlled trials - Response, CIRCULATION, 104(22), 2001, pp. E124-E124
Authors:
Ellis, SG
Brener, SJ
Lincoff, AM
Moliterno, DJ
Whitloe, PL
Schneider, JP
Citation: Sg. Ellis et al., beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise, CIRCULATION, 104(22), 2001, pp. 2685-2688
Authors:
Chew, DP
Bhatt, DL
Lincoff, AM
Moliterno, DJ
Brener, SJ
Wolski, KE
Topol, EJ
Citation: Dp. Chew et al., Optimal activated clotting time during percutaneous coronary intervention - Response, CIRCULATION, 104(15), 2001, pp. E83-E84
Authors:
Chew, DP
Bhatt, DL
Lincoff, AM
Moliterno, DJ
Brener, SJ
Wolski, KE
Topol, EJ
Citation: Dp. Chew et al., Defining the optimal activated clotting time during percutaneous coronary intervention - Aggregate results from 6 randomized, controlled trials, CIRCULATION, 103(7), 2001, pp. 961-966
Authors:
Cura, FA
L'Allier, PL
Kapadia, SR
Houghtaling, PL
Dipaola, LM
Ellis, SG
Topol, EJ
Brener, SJ
Citation: Fa. Cura et al., Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction, AM J CARD, 88(2), 2001, pp. 124-128
Authors:
Brener, SJ
Topol, EJ
Citation: Sj. Brener et Ej. Topol, Third-generation thrombolytic agents for acute myocardial infarction, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 243-270
Authors:
Brener, SJ
Citation: Sj. Brener, Combination fibrinolysis and platelet IIb/IIIa antagonism for acute myocardial infarction, ACUTE CORONARY SYNDROMES, SECOND EDITION, 2001, pp. 271-291
Authors:
Brener, SJ
Citation: Sj. Brener, Unfractionated and low-molecular-weight heparins in acute coronary syndromes: Current recommendations, CLEV CLIN J, 67(1), 2000, pp. 59-65
Authors:
Penn, MS
Smedira, N
Lytle, B
Brener, SJ
Citation: Ms. Penn et al., Does coronary angiography before emergency aortic surgery affect in-hospital mortality?, J AM COL C, 35(4), 2000, pp. 889-894
Authors:
Brener, SJ
Topol, EJ
Citation: Sj. Brener et Ej. Topol, Troponin, embolization and restoration of microvascular integrity, EUR HEART J, 21(14), 2000, pp. 1117-1119
Authors:
Cura, FA
Bhatt, DL
Lincoff, AM
Kapadia, SR
L'Allier, PL
Ziada, KM
Wolski, KE
Moliterno, DJ
Brener, SJ
Ellis, SG
Topol, EJ
Citation: Fa. Cura et al., Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions, CIRCULATION, 102(1), 2000, pp. 28-34
Authors:
Bhatt, DL
Lincoff, M
Califf, RM
Simoons, ML
Tcheng, JE
Brener, SJ
Wolski, KE
Topol, EJ
Citation: Dl. Bhatt et al., The benefit of abciximab in percutaneous coronary revascularization is notdevice-specific, AM J CARD, 85(9), 2000, pp. 1060-1064
Authors:
Brener, SJ
Ellis, SG
Sapp, SK
Betriu, A
Granger, CB
Burchenal, JEB
Moliterno, DJ
Califf, RM
Topol, EJ
Citation: Sj. Brener et al., Predictors of death and reinfarction at 30 days after primary angioplasty:The GUSTO IIb and RAPPORT trials, AM HEART J, 139(3), 2000, pp. 476-481
Authors:
Brener, SJ
Topol, EJ
Moliterno, DJ
Barr, LA
Burchenal, JEB
Katz, S
George, BS
Jones, AA
Cohen, ED
Gainey, PC
White, HJ
Cheek, HB
Moses, JW
Effron, MB
Citation: Sj. Brener et al., Rapport? Reply, CIRCULATION, 99(25), 1999, pp. 3324-3324
Authors:
Bahler, RC
Desser, DR
Finkelhor, RS
Brener, SJ
Youssefi, M
Citation: Rc. Bahler et al., Factors leading to progression of valvular aortic stenosis, AM J CARD, 84(9), 1999, pp. 1044-1048
Authors:
Brener, SJ
Barr, LA
Burchenal, JEB
Wolski, KE
Effron, MB
Topol, EJ
Citation: Sj. Brener et al., Effect of abciximab on the pattern of reperfusion in patients with acute myocardial infarction treated with primary angioplasty, AM J CARD, 84(6), 1999, pp. 728
Risultati:
1-16
|